The DOI matches its Crossref record; 38 of the 41 references it cites were found in a registry or an index.
RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
Open accessAbstract
Background The long-term health consequences of COVID-19 remain largely unclear. The aim of this study was to describe the long-term health consequences of patients with COVID-19 who have been discharged from hospital and investigate the associated risk factors, in particular disease severity.Methods We did an ambidirectional cohort study of patients with confirmed COVID-19 who had been discharged from Jin Yin-tan Hospital (Wuhan, China) between Jan 7, 2020, and May 29, 2020. Patients who died before follow-up, patients for whom follow-up would be difficult because of psychotic disorders, dementia, or re-admission to hospital, those who were unable to move freely due to concomitant osteoarthropathy or immobile before or after discharge due to diseases such as stroke or pulmonary embolism, those who declined to participate, those who could not be contacted, and those living outside of Wuhan or in nursing or welfare homes were all excluded. All patients were interviewed with a series of questionnaires for evaluation of symptoms and health-related quality of life, underwent physical examinations and a 6-min walking test, and received blood tests. A stratified sampling procedure was used to sample patients according to their highest seven-category scale during their hospital stay as 3, 4, and 5-6, to receive pulmonary function test, high resolution CT of the chest, and ultrasonography. Enrolled patients who had participated in the Lopinavir Trial for Suppression of SARS-CoV-2 in China received severe acute respiratory syndrome coronavirus 2 antibody tests. Multivariable adjusted linear or logistic regression models were used to evaluate the association between disease severity and long-term health consequences.Findings In total, 1733 of 2469 discharged patients with COVID-19 were enrolled after 736 were excluded. Patients had a median age of 57·0 (IQR 47·0-65·0) years and 897 (52%) were men. The follow-up study was done from June 16, to Sept 3, 2020, and the median follow-up time after symptom onset was 186·0 (175·0-199·0) days. Fatigue or muscle weakness (63%, 1038 of 1655) and sleep difficulties (26%, 437 of 1655) were the most common symptoms. Anxiety or depression was reported among 23% (367 of 1617) of patients. The proportions of median 6-min walking distance less than the lower limit of the normal range were 24% for those at severity scale 3, 22% for severity scale 4, and 29% for severity scale 5-6. The corresponding proportions of patients with diffusion impairment were 22% for severity scale 3, 29% for scale 4, and 56% for scale 5-6, and median CT scores were 3·0 (IQR 2·0-5·0) for severity scale 3, 4·0 (3·0-5·0) for scale 4, and 5·0 (4·0-6·0) for scale 5-6. After multivariable adjustment, patients showed an odds ratio (OR) 1·61 (95% CI 0·80-3·25) for scale 4 versus scale 3 and 4·60 (1·85-11·48) for scale 5-6 versus scale 3 for diffusion impairment; OR 0·88 (0·66-1·17) for scale 4 versus scale 3 and OR 1·77 (1·05-2·97) for scale 5-6 versus scale 3 for anxiety or depression, and OR 0·74 (0·58-0·96) for scale 4 versus scale 3 and 2·69 (1·46-4·96) for scale 5-6 versus scale 3 for fatigue or muscle weakness. Of 94 patients with blood antibodies tested at follow-up, the seropositivity (96·2% vs 58·5%) and median titres (19·0 vs 10·0) of the neutralising antibodies were significantly lower compared with at the acute phase. 107 of 822 participants without acute kidney injury and with estimated glomerular filtration rate (eGFR) 90 mL/min per 1·73 m 2 or more at acute phase had eGFR less than 90 mL/min per 1·73 m 2 at follow-up.Interpretation At 6 months after acute infection, COVID-19 survivors were mainly troubled with fatigue or muscle weakness, sleep difficulties, and anxiety or depression. Patients who were more severely ill during their hospital stay had more severe impaired pulmonary diffusion capacities and abnormal chest imaging manifestations, and are the main target population for intervention of long-term recovery.Funding National Natural Science Foundation of China, Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences, National Key Research and Development Program of China, Major Projects of National Science and Technology on New Drug Creation and Development of Pulmonary Tuberculosis, and Peking Union Medical College Foundation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Nevertheless, what emerges from preliminary data is the negative impact of long COVID on quality of life and its effects on patient work ability and social relationships [1,4,19].”
From Female gender is associated with long COVID syndrome: a prospective cohort study (2022) · cites this paper as [1]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“These mental health symptoms persist even after the acute stage of the disease.”
From Psychological treatments for the mental health symptoms among individuals infected with COVID-19: a scoping review protocol (2023) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“Further, severe lung complications from COVID-19 may have persisting limitations to respiratory function and gas exchange; this group of patients, therefore, should be the primary target population for the intervention of long-term recovery.”
From Effects of short-term breathing exercises on respiratory recovery in patients with COVID-19: a quasi-experimental study (2022) · cites this paper as [32]
The cited source says what the claim attributes to it.
In the citing paper
“Abdominal chest imaging, and severe impairment to pulmonary diffusion capacities was reported in COVID-19 patients recovered from severe illness [32].”
From Effects of short-term breathing exercises on respiratory recovery in patients with COVID-19: a quasi-experimental study (2022) · cites this paper as [32]
In the citing paper
“These symptoms can endure up to 6–7 months and even longer [[1], [2], [3], [4], [5]].”
From Female gender is associated with long COVID syndrome: a prospective cohort study (2022) · cites this paper as [1]
In the citing paper
“Advanced age was associated with ongoing fatigue and musculoskeletal pain, or impairment in pulmonary functions, reflecting a decline in organ function and a slower ability to recover [1,16].”
From Female gender is associated with long COVID syndrome: a prospective cohort study (2022) · cites this paper as [1]
In the citing paper
“Literature data are not equivocal about the association between females and long COVID: some preliminary studies have shown an increased prevalence of fatigue [24] or other symptoms among women [1,5,13,16], while in other studies no gender association was found [4,[18], [19], [20]].”
From Female gender is associated with long COVID syndrome: a prospective cohort study (2022) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Dexamethasone in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., Bonsel, G., & Badia, X. (2011) · Quality of Life Research · doi:10.1007/s11136-011-9903-x · Cited by 9,795
Standardization of Spirometry, 1994 Update. American Thoracic Society
(1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.3.7663792 · Cited by 6,605
EQ-SD: a measure of health status from the EuroQol Group
Rabin, R., & Charro, F. D. (2001) · Annals of Medicine · doi:10.3109/07853890109002087 · Cited by 5,613
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruan, L., Song, B., Cai, Y., Wei, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001282 · Cited by 5,258
Self-citationWiersinga, W. J., Rhodes, A., Cheng, A. C., Peacock, S. J., & Prescott, H. C. (2020) · JAMA · doi:10.1001/jama.2020.12839 · Cited by 4,609
Persistent Symptoms in Patients After Acute COVID-19
Carfì, A., Bernabei, R., Landi, F., & for the Gemelli Against COVID-19 Post-Acute Care Study Group (2020) · JAMA · doi:10.1001/jama.2020.12603 · Cited by 4,561
Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19)
Pan, F., Ye, T., Sun, P., Gui, S., Liang, B., Li, L., Zheng, D., Wang, J., Hesketh, R. L., Yang, L., et al. (2020) · Radiology · doi:10.1148/radiol.2020200370 · Cited by 2,915
Self-citation
Cited by
Sorted by citations
Santomauro, D. F., Mantilla Herrera, A. M., Shadid, J., Zheng, P., Ashbaugh, C., Pigott, D. M., Abbafati, C., Adolph, C., Amlag, J. O., Aravkin, A. Y., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)02143-7 · Cited by 5,444
“Emerging evidence suggests people with post-acute sequelae of COVID-19 (sometimes known as long COVID) might develop depressive and anxiety disorder symptoms, 37,38 and so prevalence of long COVID might be a potential indicator in future work.”
Nalbandian, A., Sehgal, K., Gupta, A., Madhavan, M. V., McGroder, C., Stevens, J. S., Cook, J. R., Nordvig, A. S., Shalev, D., Sehrawat, T. S., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01283-z · Cited by 4,862
Features, Evaluation and Treatment Coronavirus (COVID-19)
Cascella, M., Rajnik, M., Cuomo, A., Dulebohn, S. C., & Napoli, R. D. (2020) · StatPearls · Cited by 3,351
Long-term cardiovascular outcomes of COVID-19
Xie, Y., Xu, E., Bowe, B. C., & Al‐Aly, Z. (2022) · Nature Medicine · doi:10.1038/s41591-022-01689-3 · Cited by 2,125
Long covid—mechanisms, risk factors, and management
Crook, H., Raza, S., Nowell, J., Young, M., & Edison, P. (2021) · BMJ · doi:10.1136/bmj.n1648 · Cited by 1,655
Fatigue and cognitive impairment in Post-COVID-19 Syndrome: a systematic review and meta-analysis
Ceban, F., Ling, S., Lui, L. M. W., Lee, Y., Gill, H., Teopiz, K. M., Rodrigues, N. B., Subramaniapillai, M., Di Vincenzo, J. D., Cao, B., et al. (2022) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.12.020 · Cited by 1,554
Self-citationChen, C., Haupert, S. R., Zimmermann, L., Shi, X., Fritsche, L. G., & Mukherjee, B. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac136 · Cited by 1,448
Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments
Yong, S. J. (2021) · Infectious Diseases · doi:10.1080/23744235.2021.1924397 · Cited by 1,339
Multiple early factors anticipate post-acute COVID-19 sequelae
Su, Y., Yuan, D., Chen, D. G., Ng, R. H., Wang, K., Choi, J., Li, S., Hong, S., Zhang, R., Xie, J., et al. (2022) · Cell · doi:10.1016/j.cell.2022.01.014 · Cited by 1,156
1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study.
Huang, L., Yao, Q., Gu, X., Wang, Q., Ren, L., Wang, Y., Hu, P., Guo, L., Liu, M., Xu, J., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01755-4 · Cited by 1,101
Self-citationSymptoms and risk factors for long COVID in non-hospitalized adults
Subramanian, A., Nirantharakumar, K., Hughes, S., Myles, P. R., Williams, T., Gokhale, K. M., Taverner, T., Chandan, J. S., Brown, K. R., Simms-Williams, N., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01909-w · Cited by 1,108
Phetsouphanh, C., Darley, D. R., Wilson, D. B., Howe, A., Munier, C. M. L., Patel, S. K., Juno, J. A., Burrell, L. M., Kent, S. J., Dore, G. J., et al. (2022) · Nature Immunology · doi:10.1038/s41590-021-01113-x · Cited by 1,062
Collaborators, G. B. O. D. L. C., Hanson, S. W., Abbafati, C., Aerts, J. G. J. V., Al‐Aly, Z., Ashbaugh, C., Ballouz, T., Blyuss, O. B., Bobkova, P., Bonsel, G. J., et al. (2022) · JAMA · doi:10.1001/jama.2022.18931 · Cited by 1,015
Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection
Groff, D., Sun, A., Ssentongo, A. E., Ba, D. M., Parsons, N., Poudel, G. R., Lekoubou, A., Oh, J. S., Ericson, J. E., Ssentongo, P., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.28568 · Cited by 1,010
Symptoms, complications and management of long COVID: a review
Aiyegbusi, O. L., Hughes, S. E., Turner, G., Rivera, S. C., McMullan, C., Chandan, J. S., Haroon, S., Price, G., Davies, E. H., Nirantharakumar, K., et al. (2021) · Journal of the Royal Society of Medicine · doi:10.1177/01410768211032850 · Cited by 969
Characterising long COVID: a living systematic review
Michelen, M., Cheng, V., Manoharan, L., Elkheir, N., Dagens, A., Hastie, C., O’Hara, M. E., Suett, J. C., Dahmash, D. T., Bugaeva, P., et al. (2021) · BMJ Global Health · doi:10.1136/bmjgh-2021-005427 · Cited by 1,004
Taquet, M., Dercon, Q., Luciano, S., Geddes, J. R., Husain, M., & Harrison, P. J. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003773 · Cited by 948
Proal, A. D., & VanElzakker, M. B. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.698169 · Cited by 921
Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection
Thaweethai, T., Jolley, S. E., Karlson, E. W., Levitan, E. B., Levy, B. D., McComsey, G. A., McCorkell, L., Nadkarni, G. N., Parthasarathy, S., Singh, U., et al. (2023) · JAMA · doi:10.1001/jama.2023.8823 · Cited by 841
Self-citationRisk Factors Associated With Post−COVID-19 Condition
Tsampasian, V., Elghazaly, H., Chattopadhyay, R., Dębski, M., Naing, T. K. P., Garg, P., Clark, A., Ntatsaki, E., & Vassiliou, V. S. (2023) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2023.0750 · Cited by 879
Distinguishing features of long COVID identified through immune profiling
Klein, J., Wood, J., Jaycox, J. R., Dhodapkar, R. M., Lu, P., Gehlhausen, J. R., Tabachnikova, A., Greene, K., TABACOF, L. R., Malik, A. A., et al. (2023) · Nature · doi:10.1038/s41586-023-06651-y · Cited by 852
Premraj, L., Kannapadi, N. V., Briggs, J., Seal, S. M., Battaglini, D., Fanning, J. P., Suen, J. Y., Robba, C., Fraser, J. F., & Cho, S. (2022) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2022.120162 · Cited by 817
Nasserie, T., Hittle, M., & Goodman, S. N. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.11417 · Cited by 702
Wu, X., Liu, X., Zhou, Y., Yu, H., Li, R., Zhan, Q., Ni, F., Fang, S., Yang, L., Ding, X., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00174-0 · Cited by 715
Self-citationAugustin, M., Schommers, P., Stecher, M., Dewald, F., Gieselmann, L., Gruell, H., Horn, C., Vanshylla, K., Cristanziano, V. D., Osebold, L., et al. (2021) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2021.100122 · Cited by 715
Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus
Raman, B., Bluemke, D. A., Lüscher, T. F., & Neubauer, S. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac031 · Cited by 717
Malik, P., Patel, K., Pinto, C., Jaiswal, R., Tirupathi, R., Pillai, S., & Patel, U. K. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27309 · Cited by 670
Long COVID in a prospective cohort of home-isolated patients
Blomberg, B., Mohn, K. G.-I., Brokstad, K. A., Zhou, F., Linchausen, D. W., Hansen, B.-A., Lartey, S., Onyango, T. B., Kuwelker, K., Sævik, M., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01433-3 · Cited by 659
Pathological sequelae of long-haul COVID
Mehandru, S., & Mérad, M. (2022) · Nature Immunology · doi:10.1038/s41590-021-01104-y · Cited by 675
Female gender is associated with long COVID syndrome: a prospective cohort study
Bai, F., Tomasoni, D., Falcinella, C., Barbanotti, D., Castoldi, R., Mulè, G., Augello, M., Mondatore, D., Allegrini, M., Cona, A., et al. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.11.002 · Cited by 644
Huang, L., Li, X., Gu, X., Zhang, H., Ren, X., Guo, L., Liu, M., Wang, Y., Cui, D., Wang, Y., et al. (2022) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(22)00126-6 · Cited by 613
Self-citationUnexplained post-acute infection syndromes
Choutka, J., Jansari, V., Hornig, M., & Iwasaki, A. (2022) · Nature Medicine · doi:10.1038/s41591-022-01810-6 · Cited by 604
Jung, E., Romero, R. J., Yeo, L., Gomez‐Lopez, N., Chaemsaithong, P., Jaovisidha, A., Gotsch, F., & Erez, O. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.11.1356 · Cited by 648
Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19
Morin, L., Savale, L., Pham, T. O., Colle, R., Figueiredo, S., Harrois, A., Gasnier, M., Lecoq, A.-L., Meyrignac, O., Noël, N., et al. (2021) · JAMA · doi:10.1001/jama.2021.3331 · Cited by 612
Swank, Z., Senussi, Y., Manickas-Hill, Z., Yu, X. G., Li, J. Z., Alter, G., & Walt, D. R. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac722 · Cited by 580
Fernández‐de‐las‐Peñas, C., Palacios‐Ceña, D., Gómez‐Mayordomo, V., Florêncio, L. L., Cuadrado, M. L., Plaza‐Manzano, G., & Navarro‐Santana, M. J. (2021) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2021.06.009 · Cited by 607
Seeßle, J., Waterboer, T., Hippchen, T., Simon, J., Kirchner, M., Lim, A., Müller, B., & Merle, U. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab611 · Cited by 557
Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome
Liu, Q., Mak, J. W. Y., Su, Q., Yeoh, Y. K., Lui, G. C.-Y., Ng, S. S., Zhang, F., Li, A. Y. L., Lu, W., Hui, D. S. C., et al. (2022) · Gut · doi:10.1136/gutjnl-2021-325989 · Cited by 540
Long COVID science, research and policy
Al-Aly, Z., Davis, H., McCorkell, L., Soares, L., Wulf-Hanson, S., Iwasaki, A., & Topol, E. J. (2024) · Nature Medicine · doi:10.1038/s41591-024-03173-6 · Cited by 538
Pretorius, E., Vlok, M., Venter, C., Bezuidenhout, J. A., Laubscher, G. J., Steenkamp, J., & Kell, D. B. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01359-7 · Cited by 553
Alkodaymi, M. S., Omrani, O. A., Fawzy, N. A., Shaar, B. A., Almamlouk, R., Riaz, M. A., Obeidat, M. A., Obeidat, Y., Gerberi, D., Taha, R. M., et al. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2022.01.014 · Cited by 561
Long-term neurologic outcomes of COVID-19
Xu, E., Xie, Y., & Al-Aly, Z. (2022) · Nature Medicine · doi:10.1038/s41591-022-02001-z · Cited by 530
SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis
Wendisch, D., Dietrich, O., Mari, T., von Stillfried, S., Ibarra, I. L., Mittermaier, M., Mache, C., Chua, R. L., Knoll, R., Timm, S., et al. (2021) · Cell · doi:10.1016/j.cell.2021.11.033 · Cited by 528
Preliminary evidence on long COVID in children
Buonsenso, D., Munblit, D., Rose, C. D., Sinatti, D., Ricchiuto, A., Carfì, A., & Valentini, P. (2021) · Acta Paediatrica · doi:10.1111/apa.15870 · Cited by 508
Tabacof, L., Tosto-Mancuso, J., Wood, J., Cortes, M., Kontorovich, A., McCarthy, D., Rizk, D., Rozanski, G., Breyman, E., Nasr, L., et al. (2021) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0000000000001910 · Cited by 517
The IL-1β, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19
Schultheiß, C., Willscher, E., Paschold, L., Gottschick, C., Klee, B., Henkes, S.-S., Henkes, S.-S., Bosurgi, L., Sedding, D., Sedding, D., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100663 · Cited by 487
Wong, T. L., & Weitzer, D. (2021) · Medicina · doi:10.3390/medicina57050418 · Cited by 473
Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study
Daugherty, S. E., Guo, Y., Heath, K., Dasmariñas, M. C., Jubilo, K. G., Samranvedhya, J., Lipsitch, M., & Cohen, K. (2021) · BMJ · doi:10.1136/bmj.n1098 · Cited by 437
Long-term complications of COVID-19
Desai, A. D., Lavelle, M. P., Boursiquot, B. C., & Wan, E. Y. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00375.2021 · Cited by 458
Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract
Flerlage, T., Boyd, D. F., Meliopoulos, V., Thomas, P. G., & Schultz‐Cherry, S. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00542-7 · Cited by 419
Psychiatric and neuropsychiatric sequelae of COVID-19 – A systematic review
Schou, T. M., Joca, S. R. L., Wegener, G., & Bay-Richter, C. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.07.018 · Cited by 424
Pavli, A., Theodoridou, M., & Maltezou, H. C. (2021) · Archives of Medical Research · doi:10.1016/j.arcmed.2021.03.010 · Cited by 426
Evans, R. A., Leavy, O. C., Richardson, M., Elneima, O., McAuley, H., Shikotra, A., Singapuri, A., Sereno, M., Saunders, R., Harris, V. C., et al. (2022) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(22)00127-8 · Cited by 413
Emerging Variants of SARS-CoV-2 And Novel Therapeutics Against Coronavirus (COVID-19)
Aleem, A., Samad, A., & Slenker, A. K. (2021) · Europe PMC (PubMed Central) · Cited by 398
Alimoradi, Z., Broström, A., Tsang, H. W. H., Griffiths, M. D., Haghayegh, S., Ohayon, M. M., Lin, C., & Pakpour, A. H. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.100916 · Cited by 415
Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation
Gold, J. E., Okyay, R. A., Licht, W. E., & Hurley, D. J. (2021) · Pathogens · doi:10.3390/pathogens10060763 · Cited by 385
Song, W., Hui, C., Hull, J. H., Birring, S. S., McGarvey, L. P., Mazzone, S. B., & Chung, K. F. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00125-9 · Cited by 386
COVID-19 and Cardiovascular Disease
Chung, M. K., Zidar, D. A., Bristow, M. R., Cameron, S. J., Chan, T. A.-T., Harding, C. V., Kwon, D. H., Singh, T. K., Tilton, J. C., Tsai, E. J., et al. (2021) · Circulation Research · doi:10.1161/circresaha.121.317997 · Cited by 377
Miskowiak, K., Johnsen, S., Sattler, S., Nielsen, S., Kunalan, K., Rungby, J., Lapperre, T., & Porsberg, C. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.03.019 · Cited by 365
Frequency, signs and symptoms, and criteria adopted for long COVID‐19: A systematic review
Martimbianco, A. L. C., Pacheco, R. L., Bagattini, Â. M., & Riera, R. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14357 · Cited by 370
Post-COVID-19 Syndrome and the Potential Benefits of Exercise
Jimeno‐Almazán, A., Pallarés, J. G., Buendía‐Romero, Á., Martínez-Cava, A., Franco‐López, F., Martínez, B. J. S.-Á., Bernal, E., & Courel‐Ibáñez, J. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18105329 · Cited by 382
Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic
To, K. K., Sridhar, S., Chiu, K. H., Hung, D. L. L., Li, X., Hung, I. F., Tam, A. R., Chung, T. W., Chan, J. F., Zhang, J., et al. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.1898291 · Cited by 359
Self-citationLong COVID, a comprehensive systematic scoping review
Akbarialiabad, H., Taghrir, M. H., Abdollahi, A., Ghahramani, N., Kumar, M., Paydar, S., Razani, B., MWANGI, J. K., Asadi‐Pooya, A. A., Malekmakan, L., et al. (2021) · Infection · doi:10.1007/s15010-021-01666-x · Cited by 367
Menges, D., Ballouz, T., Anagnostopoulos, A., Aschmann, H. E., Domenghino, A., Fehr, J. S., & Puhan, M. A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0254523 · Cited by 359
Wang, W., Wang, C.-Y., Wang, S., & Wei, J. C. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101619 · Cited by 343
Self-citationOsmanov, I. M., Spiridonova, E., Bobkova, P., Gamirova, A., Shikhaleva, A., Andreeva, M., Blyuss, O. B., El-Taravi, Y., DunnGalvin, A., Comberiati, P., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.01341-2021 · Cited by 352
Persistent Exertional Intolerance After COVID-19
Singh, I., Joseph, P., Heerdt, P. M., Cullinan, M., Lutchmansingh, D. D., Gulati, M., Possick, J. D., Systrom, D. M., & Waxman, A. B. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.08.010 · Cited by 338
Zeng, N., Zhao, Y., Yan, W., Li, C., Lu, Q.-D., Liu, L., Ni, S., Mei, H., Yuan, K., Shi, L., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01614-7 · Cited by 352
Self-citationSigfrid, L., Drake, T. M., Pauley, E., Jesudason, E. C., Olliaro, P., Lim, W. S., Gillesen, A., Berry, C., Lowe, D. J., McPeake, J. M., et al. (2021) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2021.100186 · Cited by 345
COVID-19, Hyperglycemia, and New-Onset Diabetes
Khunti, K., Prato, S. D., Mathieu, C., Kahn, S. E., Gabbay, R. A., & Buse, J. B. (2021) · Diabetes Care · doi:10.2337/dc21-1318 · Cited by 342
Years of life lost to COVID-19 in 81 countries
Pifarré i Arolas, H., Acosta, E., López-Casasnovas, G., Lo, A., Nicodemo, C., Riffe, T., & Myrskylä, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-83040-3 · Cited by 312
Preeclampsia and eclampsia: the conceptual evolution of a syndrome
Erez, O., Romero, R. J., Jung, E., Chaemsaithong, P., Bosco, M., Suksai, M., Gallo, D. M., & Gotsch, F. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.12.001 · Cited by 322
Peghin, M., Palese, A., Venturini, M., Martino, M. D., Gerussi, V., Graziano, E., Bontempo, G., Marrella, F., Tommasini, A., Fabris, M., et al. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.05.033 · Cited by 320
Chronic Fatigue and Postexertional Malaise in People Living With Long COVID: An Observational Study
Twomey, R., DeMars, J., Franklin, K., Culos-Reed, S. N., Weatherald, J. C., & Wrightson, J. G. (2022) · Physical Therapy · doi:10.1093/ptj/pzac005 · Cited by 326
Fernández‐de‐las‐Peñas, C., Martín‐Guerrero, J. D., Pellicer-Valero, Ó. J., Navarro‐Pardo, E., Gómez‐Mayordomo, V., Cuadrado, M. L., Navalón, J. A. A., Cigarán‐Méndez, M., Hernández‐Barrera, V., & Arendt‐Nielsen, L. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11020413 · Cited by 316
SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19
Gusev, E., Sarapultsev, A., Владимировна, С. Л., & Черешнев, В. А. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031716 · Cited by 326
Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19
Lowery, S. A., Sariol, A., & Perlman, S. M. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.05.004 · Cited by 303
Koc, H. C., Xiao, J., Liu, W., Li, Y., & Chen, G. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.75056 · Cited by 310
Self-citationCourse of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort
Tran, V.-T., Porcher, R., Pane, I., & Ravaud, P. (2022) · Nature Communications · doi:10.1038/s41467-022-29513-z · Cited by 290
Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis
Badenoch, J., Rengasamy, E. R., Watson, C. J., Jansen, K., Chakraborty, S., Sundaram, R. D., Hafeez, D., Burchill, E., Saini, A., Thomas, L., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab297 · Cited by 288
Nopp, S., Moik, F., Klok, F. A., Gattinger, D., Petrovic, M., Vonbank, K., Koczulla, A. R., Ay, C., & Zwick, R. H. (2022) · Respiration · doi:10.1159/000522118 · Cited by 303
Tenforde, M. W., Olson, S. M., Self, W. H., Talbot, H. K., Lindsell, C. J., Steingrub, J. S., Shapiro, N. I., Ginde, A. A., Douin, D. J., Prekker, M. E., et al. (2021) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7018e1 · Cited by 286
Sex differences in sequelae from COVID-19 infection and in long COVID syndrome: a review
Sylvester, S. V., Rusu, R., Chan, B., Bellows, M., O’Keefe, C., & Nicholson, S. (2022) · Current Medical Research and Opinion · doi:10.1080/03007995.2022.2081454 · Cited by 290
Kell, D. B., Laubscher, G. J., & Pretorius, E. (2022) · Biochemical Journal · doi:10.1042/bcj20220016 · Cited by 278
Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection
Ryan, F. J., Hope, C. M., Masavuli, M. G., Lynn, M. A., Mekonnen, Z. A., Yeow, A. E. L., García-Valtanen, P., Al-Delfi, Z., Gummow, J., Ferguson, C. C., et al. (2022) · BMC Medicine · doi:10.1186/s12916-021-02228-6 · Cited by 288
Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications
Zhang, F., Lau, R. I., Liu, Q., Su, Q., Chan, F. K. L., & Ng, S. C. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00698-4 · Cited by 282
Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning
Drucker, D. J. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.01.016 · Cited by 272
Li, J., Xia, W., Zhan, C., Liu, S., Yin, Z., Wang, J., Chong, Y., Zheng, C., Fang, X., Cheng, W., et al. (2021) · Thorax · doi:10.1136/thoraxjnl-2021-217382 · Cited by 281
Self-citationSalamanna, F., Veronesi, F., Martini, L., Landini, M. P., & Fini, M. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.653516 · Cited by 288
Montani, D., Savale, L., Noël, N., Meyrignac, O., Colle, R., Gasnier, M., Corruble, E., Beurnier, A., Jutant, E., Pham, T. O., et al. (2022) · European Respiratory Review · doi:10.1183/16000617.0185-2021 · Cited by 277
Post-COVID syndrome. A case series and comprehensive review
Anaya, J., Rojas, M., Salinas, M. L., Rodríguez, Y., Roa, G., Lozano, M., Rodríguez‐Jiménez, M., Montoya, N., Zapata, E., Post-COVID study group, et al. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102947 · Cited by 269
Neurological manifestations of long-COVID syndrome: a narrative review
Stefanou, M., Palaiodimou, L., Bakola, E., Smyrnis, N., Papadopoulou, Μ., Paraskevas, G. P., Rizos, E., Boutati, E. I., Grigoriadis, N., Krogias, C., et al. (2022) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223221076890 · Cited by 267
Three waves changes, new variant strains, and vaccination effect against COVID-19 pandemic
El-Shabasy, R. M., Nayel, M. A., Taher, M. M., Abdelmonem, R., Shoueir, K. R., & Kenawy, E. R. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.01.118 · Cited by 269
Benefits of pulmonary rehabilitation in COVID-19: a prospective observational cohort study
Gloeckl, R., Leitl, D., Jarosch, I., Schneeberger, T., Nell, C., Stenzel, N., Vogelmeier, C. F., Kenn, K., & Koczulla, A. R. (2021) · ERJ Open Research · doi:10.1183/23120541.00108-2021 · Cited by 256
Pretorius, E., Venter, C., Laubscher, G. J., Kotze, M., Oladejo, S. O., Watson, L., Rajaratnam, K., Watson, B., & Kell, D. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01579-5 · Cited by 209
Long COVID: pathophysiological factors and abnormalities of coagulation
Turner, S., Khan, A., Putrino, D. F., Woodcock, A. A., Kell, D. B., & Pretorius, E. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.03.002 · Cited by 247
Cytokine Profiles Associated With Acute COVID-19 and Long COVID-19 Syndrome
Queiroz, M. A. F., das Neves, P. F. M., Lima, S. S., Lopes, J. D. C., Torres, M. K. D. S., Vallinoto, I. M. V. C., Bichara, C. D. A., dos Santos, E. F., de Brito, M. T. F. M., da Silva, A. L. S., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.922422 · Cited by 253
Peluso, M. J., Deitchman, A. N., Torres, L., Iyer, N. S., Munter, S. E., Nixon, C. C., Donatelli, J. L., Thanh, C., Takahashi, S., Hakim, J. M. C., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109518 · Cited by 251
More Than 100 Persistent Symptoms of SARS-CoV-2 (Long COVID): A Scoping Review
Hayes, L. D., Ingram, J., & Sculthorpe, N. F. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.750378 · Cited by 255
Post-COVID Syndrome: An Insight on Its Pathogenesis
Maltezou, H. C., Pavli, A., & Tsakris, A. (2021) · Vaccines · doi:10.3390/vaccines9050497 · Cited by 253
Metadata
- Authors
- Huang, C., Huang, L., Wang, Y., Li, X., Ren, L., Gu, X., Kang, L., Guo, L., Liu, M., Zhou, X., Luo, J., Huang, Z., Tu, S., Zhao, Y., Chen, L., Xu, D., Li, Y., Li, C., Peng, L., Li, Y., Xie, W., Cui, D., Shang, L., Fan, G., Xu, J., Wang, G., Wang, Y., Zhong, J., Wang, C., Wang, J., Zhang, D., & Cao, B.
- Affiliations
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Capital Medical University (CN)
- China-Japan Friendship Hospital (CN)
- Jinyintan Hospital (CN)
- Peking University (CN)
- Harbin Medical University (CN)
- Beijing University of Chinese Medicine (CN)
- Tsinghua University (CN)
- Corresponding author
- Cao, Bin
- ORCID
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2021-01
- Volume
- 397
- Issue
- 10270
- Pages
- 220-232
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- PMC
- PMC7833295
- OpenAlex
- W3120387768
- Cited by
- 4,084
- References
- 41
- Citations by year
- 2026: 67 · 2025: 180 · 2024: 510 · 2023: 934 · 2022: 1300 · 2021: 1088
- FWCI
- 458.37
- Type
- journal article
- Language
- en
- Status
- Retracted
- Open access
- bronze
- doi.org
- Locations
- The Lancet (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Science and Technology Major Project (2020ZX09201001)
- Chinese Academy of Medical Sciences (2020-I2M-CoV19\u2013005)
- National Natural Science Foundation of China (82041011/H0104)
- National Key Research and Development Program of China (2018YFC1200102)
- China-Japan Friendship Hospital
- Topics
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Keywords
- COVID-19 pandemic, long-term health effects, long COVID, fatigue, muscle weakness, sleep disorders, anxiety, depression, disease severity, health-related quality of life, physical function, lung function, SARS-CoV-2, retraction, Wuhan, post-discharge follow-up, risk factors, lopinavir
- MeSH terms
- COVID-19, SARS-CoV-2, COVID-19 Serological Testing, Post-Acute COVID-19 Syndrome, Aged, China, Fatigue, Female, Humans, Length of Stay, Male, Middle Aged, Quality of Life, Surveys and Questionnaires, Severity of Illness Index, Sleep Wake Disorders, Cohort Studies, Comorbidity, Muscle Weakness, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
